Evaluation of Analytical Agreement Between High-performance Liquid Chromatography and Capillary Electrophoresis for Haemoglobin A2 Quantification: A Meta-analysis
Main Article Content
Abstract
Background: Haemoglobin A2 (HbA2) measurement is essential for diagnosing -thalassemia carriers, yet even small analytical biases may affect clinical interpretation near the diagnostic threshold of 3.5%. High-performance liquid chromatography (HPLC) and capillary electrophoresis (CE) are widely used, but their agreement remains uncertain. The study aimed to systematically evaluate the measurement bias between HPLC and CE in HbA2 quantification.
Methods: A systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible studies directly compared HbA2 values measured by HPLC and CE in the same samples. Data on mean bias, standard deviation (SD), and limits of agreement (LoA) were extracted. A random-effects model was used to pool mean bias, and subgroup analyses were performed for normal individuals, β-thalassemia carriers, and haemoglobin variant carriers. Sensitivity analysis was conducted to assess robustness.
Results: Ten studies with 1,881 paired measurements were included. After excluding datasets with clear co-elution interference (mainly HbE and Hb Hope), the pooled mean bias was 0.16% (95% confidence interval [CI]: 0.03, 0.29), with high heterogeneity (I2 = 99.5). Subgroup analysis showed a mean bias of 0.37% (95% CI: 0.24, 0.50) in healthy individuals and 0.39% (95% CI: 0.20, 0.59) in β-thalassemia carriers. Sensitivity analysis confirmed the stability of the results.
Conclusion: HPLC and CE demonstrate systematic but clinically relevant differences in HbA2 measurement, particularly near diagnostic thresholds. HbA2 measurement results obtained from HPLC and CE should not be used interchangeably, and method-specific interpretation and harmonisation efforts are warranted.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Bain BJ, Daniel Y, Henthorn J, de la Salle B, Hogan A, Roy NBA, et al. Significant haemoglobinopathies: a guideline for screening and diagnosis. Br J Haematol. 2023;201(6):1047–1065. https://doi.org/10.1111/bjh.18794
Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol. 2009;62(1):13–17. https://doi.org/10.1136/jcp.2008.056945
Ghosh K, Colah R, Choudhry V, Das R, Manglani M, Madan N, et al. Guidelines for screening, diagnosis, and management of hemoglobinopathies. Indian J Hum Genet. 2014;20(2):101–119. https://doi.org/10.4103/0971-6866.142841
da Fonseca SF, Amorim T, Purificação A, Gonçalves M, Boa-Sorte N. Hemoglobin A2 values in sickle cell disease patients quantified by high-performance liquid chromatography and the influence of alpha thalassemia. Rev Bras Hematol Hemoter. 2015;37(5):296–301. https://doi.org/10.1016/j.bjhh.2015.05.005
Higgins TN, Khajuria A, Mack M. Quantification of HbA2 in patients with and without β-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems. Am J Clin Pathol. 2009;131(3):357–362. https://doi.org/10.1309/AJCP28QKSOPHYOBC
Ke P, Liu J, Chao Y, Wu X, Xiong Y, Lin L, et al. Measurement of HbA1c and HbA2 by Capillarys 2 Flex Piercing HbA1c programme for simultaneous management of diabetes and screening for thalassemia. Biochem Med. 2017;27(3):030704. https://doi.org/10.11613/BM.2017.030704
Giambona A, Passarello C, Vinciguerra M, Muli RL, Teresi P, Anza M, et al. Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of β-thalassemia. Haematologica. 2008;93(9):1380–1384. https://doi.org/10.3324/haematol.12840
Stephens AD, Colah R, Fucharoen S, Hoyer J, Keren D, McFarlane A, et al. ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2. Int J Lab Hematol. 2015;37(5):577–582. https://doi.org/10.1111/ijlh.12413
Stephens AD, Angastiniotis M, Baysal E, Chan V, Fucharoen S, Giordano PC, et al. ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol. 2012;34(1):1–13. https://doi.org/10.1111/j.1751-553X.2011.01368.x
Ou C-N, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin Chim Acta. 2001;313(1–2):187–194. https://doi.org/10.1016/S0009-8981(01)00672-6
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71. https://doi.org/10.1136/bmj.n71
Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009
Williamson PR, Lancaster GA, Craig JV, Smyth RL. Meta‐analysis of method comparison studies. Stat Med. 2002;21(14):2013–2025. https://doi.org/10.1002/sim.1158
Tipton E, Shuster J. A framework for the meta‐analysis of Bland–Altman studies based on a limits of agreement approach. Stat Med. 2017;36(23):3621–3635. https://doi.org/10.1002/sim.7352
Çakır Madenci Ö, Hürmeydan Ö, Orçun A, Erdoğmuş F. Comparison of capillary zone electrophoresis with high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Turk J Hematol. 2023;40(4):258–265. https://doi.org/10.4274/tjh.galenos.2023.2023.0114
Panyasai S, Sakkhachornphop S, Pornprasert S. Diagnosis of compound heterozygous Hb Tak/β-thalassemia and HbD-Punjab/β-thalassemia by HbA2 levels on capillary electrophoresis. Indian J Hematol Blood Transfus. 2018;34(1):110–114. https://doi.org/10.1007/s12288-017-0810-3
Degandt S, Coens R, Cauwelier B, Devos H, Langlois M, Emmerechts J. Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis. J Clin Lab Anal. 2018;32(1):e22224. https://doi.org/10.1002/jcla.22224
Myburgh JK, Szydlo RM, Bain BJ. The accuracy of haemoglobin A2 measurements in the presence and absence of haemoglobin S. eJHaem. 2023;4(2):437–441. https://doi.org/10.1002/jha2.691
Satthakarn S, Panyasai K, Phasit A, Panyasai S. Reliability of hemoglobin A2 value as measured by the Premier Resolution system for screening of β-thalassemia carriers. Clin Chem Lab Med. 2024;62(3):453–463. https://doi.org/10.1515/cclm-2023-1006
Poventud-Fuentes I, Garnett E, Vispo B, Elghetany MT, Devaraj S. Hemoglobin fractionation by Sebia Capillarys 2 Flex Piercing System as primary method for evaluation of hemoglobinopathies. Clin Chim Acta. 2021;519:193–197. https://doi.org/10.1016/j.cca.2021.04.023
Panyasai S, Sukunthamala K, Jaiping K, Wongwiwatthananukit S, Singboottra P, Pornprasert S. Interference of hemoglobin hope on β-thalassemia diagnosis by the capillary electrophoresis method. Am J Clin Pathol. 2011;136(1):14–18. https://doi.org/10.1309/AJCP1BT2MGATKFHL
Kasmi C, Amri Y, Hadj-Fredj S, Oueslati S, Dabboussi M, Mahjoub R, et al. Analysis of δ-globin gene alleles in Tunisians: description of three new delta-thalassemia mutations. Mol Biol Rep. 2021;48(8):5923–5933. https://doi.org/10.1007/s11033-021-06592-7
Pornprasert S, Jaiping K. Blood transfusion from a Hb E trait donor can affect β-thalassemia diagnosis. Hemoglobin. 2014;38(4):295–298. https://doi.org/10.3109/03630269.2014.926913
Colaco S, Nadkarni A. Borderline HbA2 levels: dilemma in diagnosis of beta-thalassemia carriers. Mutat Res/Rev Mutat Res. 2021;788:108387. https://doi.org/10.1016/j.mrrev.2021.108387
Ivaldi G, Barberio G, Harteveld CL, Giordano P. HbA2 measurements in β-thalassemia and in other conditions. Thalass Rep. 2014;4(2):1832. https://doi.org/10.4081/thal.2014.1832
Wada Y. Advanced analytical methods for hemoglobin variants. J Chromatogr B. 2002;781(1–2):291–301. https://doi.org/10.1016/S1570-0232(02)00558-5
Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem. 2004;50(10):1736–1747. https://doi.org/10.1373/clinchem.2004.034991
Li Y-Q, Huang H-P, Chen Z-Z, Zhao, L, Liang L, Qin, G-F, et al. Comparison of capillary electrophoresis and high performance liquid chromatography for detection and quantification of hemoglobin New York. Clin Chem Lab Med. 2016;54(1):91–95. https://doi.org/10.1515/cclm-2015-0238
Phasit A, Panyasai S, Mayoon M, Jettawan N, Satthakarn S. Phenotypic expression of known and novel hemoglobin A2-variants, hemoglobin A2-Mae Phrik [Delta 52(D3) Asp > Gly, HBD:c.158A > G], associated with hemoglobin E [Beta 26(B8) Glu > Lys, HBB:c.79G > A] in Thailand. Genes. 2022;13(6):959. https://doi.org/10.3390/genes13060959
Keren DF, Hedstrom D, Gulbranson R, Ou C-N, Bak R. Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol. 2008;130(5):824–831. https://doi.org/10.1309/AJCPQY80HZWHHGZF
Keren[ES37.1] DF, Hedstrom D, Gulbranson R, Ou CN, Bak R. Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol. 2008;130(5):824–831. https://doi.org/10.1309/AJCPQY80HZWHHGZF
Higgins V, Volodko N, Parker ML, Estey MP, Proctor D, Olayinka L, et al. Capillary electrophoresis mis-anchoring in a case of Hb Hope with HbE. Clin Biochem. 2025;139:110990. https://doi.org/10.1016/j.clinbiochem.2025.110990
Greene DN, Pyle AL, Chang JS, Hoke C, Lorey T. Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. Clin Chim Acta. 2012;413(15–16):1232–1238. https://doi.org/10.1016/j.cca.2012.03.027
Paleari R, Mosca A. Standardization of the HbA2 assay. EJIFCC. 2018;29(4):298–302.
Mosca A, Paleari R, Harteveld CL. A roadmap for the standardization of hemoglobin A2. Clin Chim Acta. 2021;512:185–190. https://doi.org/10.1016/j.cca.2020.11.008
Paleari R, Giambona A, Cannata M, Leto F, Maggio A, Mosca A, et al. External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems. Clin Chem Lab Med. 2007;45(1):88–92. https://doi.org/10.1515/CCLM.2007.002
Paleari R, Gulbis B, Cotton F, Mosca A. Interlaboratory comparison of current high‐performance methods for HbA2. Int J Lab Hematol. 2012;34(4):362–368. https://doi.org/10.1111/j.1751-553X.2012.01403.x
Paleari R, Muñoz A, Mosca A. Towards the development of a certified reference material for hemoglobin A2. Clin Chem Lab Med. 2010;48(11):1611–1618. https://doi.org/10.1515/CCLM.2010.317
Little RR, Rohlfing CL. HbA1c standardization: background, progress and current issues. Lab Med. 2009;40(6):368–373. https://doi.org/10.1309/LM3DUSEIBXHTVZ70
Perseu L, Satta S, Moi P, Demartis FR, Manunza L, Sollaino MC, et al. KLF1 gene mutations cause borderline HbA2. Blood. 2011;118(16):4454–4458. https://doi.org/10.1182/blood-2011-04-345736
Kensert A, Bosten E, Collaerts G, Efthymiadis K, van Broeck P, Desmet G, et al. Convolutional neural network for automated peak detection in reversed-phase liquid chromatography. J Chromatogr A. 2022;1672:463005. https://doi.org/10.1016/j.chroma.2022.463005